Chenming Xu

549 total citations
22 papers, 310 citations indexed

About

Chenming Xu is a scholar working on Molecular Biology, Pediatrics, Perinatology and Child Health and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Chenming Xu has authored 22 papers receiving a total of 310 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Pediatrics, Perinatology and Child Health and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Chenming Xu's work include Reproductive Biology and Fertility (4 papers), Pregnancy and preeclampsia studies (3 papers) and Prenatal Screening and Diagnostics (3 papers). Chenming Xu is often cited by papers focused on Reproductive Biology and Fertility (4 papers), Pregnancy and preeclampsia studies (3 papers) and Prenatal Screening and Diagnostics (3 papers). Chenming Xu collaborates with scholars based in China, United States and Canada. Chenming Xu's co-authors include Qiwen Shi, Hang Zhao, Lan Zhao, Hang Zhao, Xiaohong Chen, Weike Su, Xiujuan Cai, Yang Wang, Yuanlei Lou and Fen Liu and has published in prestigious journals such as Journal of Clinical Oncology, Science Advances and Frontiers in Immunology.

In The Last Decade

Chenming Xu

19 papers receiving 305 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chenming Xu China 9 130 53 50 45 41 22 310
Zishui Fang China 12 161 1.2× 57 1.1× 44 0.9× 52 1.2× 18 0.4× 34 430
Zongji Shen China 14 202 1.6× 90 1.7× 71 1.4× 103 2.3× 54 1.3× 22 499
Hisayo Kubota Japan 14 118 0.9× 57 1.1× 47 0.9× 34 0.8× 24 0.6× 25 457
Huiming Ma China 10 154 1.2× 51 1.0× 126 2.5× 80 1.8× 62 1.5× 29 421
Xiuli Chen China 11 182 1.4× 73 1.4× 28 0.6× 41 0.9× 13 0.3× 44 369
Ana Lı́a Errecalde Argentina 10 78 0.6× 51 1.0× 134 2.7× 102 2.3× 40 1.0× 24 354
Aiko Aoki Japan 11 182 1.4× 98 1.8× 45 0.9× 20 0.4× 32 0.8× 16 503
Yuzhen Ma China 13 149 1.1× 25 0.5× 121 2.4× 65 1.4× 54 1.3× 29 379
A Fidanza United Kingdom 14 252 1.9× 77 1.5× 73 1.5× 30 0.7× 38 0.9× 49 502
David Morales United States 4 286 2.2× 64 1.2× 25 0.5× 31 0.7× 31 0.8× 5 540

Countries citing papers authored by Chenming Xu

Since Specialization
Citations

This map shows the geographic impact of Chenming Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chenming Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chenming Xu more than expected).

Fields of papers citing papers by Chenming Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chenming Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chenming Xu. The network helps show where Chenming Xu may publish in the future.

Co-authorship network of co-authors of Chenming Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Chenming Xu. A scholar is included among the top collaborators of Chenming Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chenming Xu. Chenming Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xu, Chenming, et al.. (2025). OTSSP167 suppresses TNBC brain metastasis via ROS-driven P38/JNK and FAK/ERK pathways. European Journal of Pharmacology. 1004. 178017–178017.
2.
Deng, Zhiping, Chenming Xu, Ziqian Yang, et al.. (2025). Post-translational modifications of SOG1 enable dynamic control of plant DNA damage response. Science Advances. 11(38). eadw9803–eadw9803.
3.
Ma, Rong, Mengdong Ma, Chenming Xu, Hong Yu, & Xueling Fan. (2025). Research on electromagnetic ultrasonic and eddy current composite detection method for cracks in aircraft aluminum alloy plates. Aircraft Engineering and Aerospace Technology. 97(8). 888–900.
4.
Li, Siming, Yanxia Shi, Haiying Dong, et al.. (2024). Phase 2 Trial of Enfortumab Vedotin in Patients With Previously Treated Locally Advanced or Metastatic Urothelial Carcinoma in China. Cancer Medicine. 13(21). e70368–e70368. 4 indexed citations
6.
Chen, Songchang, et al.. (2022). High normal sized CGG repeat on the FMR1 gene reduces live birth rates after in vitro fertilization in Han Chinese. Gene. 819. 146204–146204. 1 indexed citations
7.
8.
Zhou, Zhiyang, et al.. (2022). Associations of Sperm mtDNA Copy Number, DNA Fragmentation Index, and Reactive Oxygen Species With Clinical Outcomes in ART Treatments. Frontiers in Endocrinology. 13. 849534–849534. 12 indexed citations
9.
Hu, Bin, et al.. (2021). Mitochondrial DNA 4977 bp Deletion in Peripheral Blood Is Associated With Polycystic Ovary Syndrome. Frontiers in Endocrinology. 12. 675581–675581. 13 indexed citations
10.
Liu, Xueli, et al.. (2021). Mitochondrial DNA Content May Not Be a Reliable Screening Biomarker for Live Birth After Single Euploid Blastocyst Transfer. Frontiers in Endocrinology. 12. 762976–762976. 5 indexed citations
11.
Hao, Yanhui, Lanlan Zhang, Songchang Chen, et al.. (2020). Associations of mitochondrial DNA copy number and deletion rate with early pregnancy loss. Mitochondrion. 55. 48–53. 6 indexed citations
13.
Xu, Chenming, et al.. (2018). SOCS-1 Suppresses Inflammation Through Inhibition of NALP3 Inflammasome Formation in Smoke Inhalation-Induced Acute Lung Injury. Inflammation. 41(4). 1557–1567. 26 indexed citations
14.
Xu, Chenming, et al.. (2018). High molecular weight hyaluronan attenuates fine particulate matter-induced acute lung injury through inhibition of ROS-ASK1-p38/JNK-mediated epithelial apoptosis. Environmental Toxicology and Pharmacology. 59. 190–198. 63 indexed citations
15.
Huang, Jiahui, Shumin Zhou, Xin Niu, et al.. (2017). Generation of special autosomal dominant polycystic kidney disease iPSCs with the capability of functional kidney-like cell differentiation. Stem Cell Research & Therapy. 8(1). 196–196. 58 indexed citations
16.
Xu, Chenming, Yating Ma, Xiaohong Chen, et al.. (2017). SOCS-1 ameliorates smoke inhalation-induced acute lung injury through inhibition of ASK-1 activity and DISC formation. Clinical Immunology. 191. 94–99. 10 indexed citations
17.
Hou, Ningning, Songchang Chen, Feng Chen, et al.. (2016). Association between premature ovarian failure, polymorphisms in MTHFR and MTRR genes and serum homocysteine concentration. Reproductive BioMedicine Online. 32(4). 407–413. 14 indexed citations
18.
Xu, Jing, Dongping Chen, Zhiguo Mao, et al.. (2013). Autosomal dominant polycystic kidney disease with ectopic unilateral multicystic dysplastic kidney. BMC Nephrology. 14(1). 38–38. 3 indexed citations
19.
Lv, Rong, et al.. (2010). Impact of Clinical Condition at Restarting Dialysis on Outcome After Kidney Allograft Loss: A Single-Center Experience. Transplantation Proceedings. 42(5). 1708–1712. 1 indexed citations
20.
Li, Zhongxiang, Tingting Wang, Yanting Wu, et al.. (2008). Adriamycin induces H2AX phosphorylation in human spermatozoa. Asian Journal of Andrology. 10(5). 749–757. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026